September 21, 2020

Efficacy of povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2

By: Judy Mathias

Editor's Note

This controlled, in-vitro study investigates the minimum contact time for povidone-iodine nasal antiseptic to inactivate the SARS-CoV-2 virus. All laboratory work was conducted in biosafety level 3 laboratories at the Institute for Antiviral Research at Utah State University, Logan.

Povidone-iodine was tested at diluted concentrations of 0.5%, 1.25%, and 2.5% and compared with controls at time periods of 15 and 30 seconds.

Sponsored Message

Test media infected with SARS-CoV-2 demonstrated complete inactivation of the virus with concentrations of povidone-iodine nasal antiseptic as low as 0.5% after 15 seconds of contact.

Use of povidone-iodine nasal antiseptic in patients before intranasal surgical procedures could significantly decrease the risk of virus transmission via droplet and aerosol spread, the researchers say. Nasal povidone-iodine irrigations also should be considered for use by healthcare professionals for prophylaxis every 4 hours, or whenever donning or doffing their masks in high-risk settings.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat